Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
Lists
Only you see this
Abstract
Maternal urinary CTX, a bone resorption marker, rises through pregnancy, although to a lesser degree with gestational cholecalciferol supplementation, and is inversely associated with maternal bone mass postpartum.This trial was registered at www.isrctn.com as ISRCTN 82927713 and eudract.ema.europa.eu as EudraCT 2007-001716-23.
BibTeX
@inproceedings{curtis2021bone,
author = {Elizabeth Curtis and Camille Parsons and Kate Maslin and Stefania D’Angelo and Rebecca J Moon and Sarah Crozier and Fatma Gossiel and Nicholas Bishop and Stephen Kennedy and Aris T. Papageorghiou and Robert Fraser and Saurabh Gandhi and Ann Prentice and Hazel Inskip and Keith M. Godfrey and Inez Schoenmakers and M K Javaid and Richard Eastell and Cyrus Cooper and Nicholas C. Harvey},
title = {{Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial}},
booktitle = {American},
year = {2021},
doi = {10.1093/ajcn/nqab264},
}Loading related content...